Orgenesis Inc.
ORGS
Rank in Stocks
#33741
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell... Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.
Share Price
$0.35
Last synced: 2026-11-06
Market Cap
$16.50M
Change (1 day)
-12.50%
Change (1 year)
118.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Orgenesis Inc. (ORGS)
Category
Healthcare
Operating Margin for Orgenesis Inc. (ORGS)
Operating Margin as of November 2026 TTM: -10,120.00%
According to Orgenesis Inc.'s latest financial reports, its current operating margin (TTM) is -10,120.00%. At the end of 2023 the company had an operating margin of -10,120.00%.
Operating Margin history for Orgenesis Inc. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -10,120.00% | 0.00% |
| 2023 | -10,120.00% | 48,251.65% |
| 2022 | -20.93% | -55.77% |
| 2021 | -47.32% | -96.22% |
| 2020 | -1,251.71% | 1,591.96% |
| 2019 | -73.98% | -5.79% |
| 2018 | -78.53% | -29.45% |
| 2017 | -111.31% | -163.14% |
| 2016 | 176.29% | -172.71% |
| 2015 | -242.47% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -99.99% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Orgenesis Inc.'s operating margin
What is Orgenesis Inc.'s operating margin?
Orgenesis Inc.'s operating margin is -10,120.00%, as of Nov 2026.
What was Orgenesis Inc.'s operating margin in 2023?
In 2023, Orgenesis Inc.'s operating margin was -10,120.00%, compared with -20.93% in 2022.
How has Orgenesis Inc.'s operating margin changed since 2018?
From 2018 to 2023, Orgenesis Inc.'s operating margin was highest in 2022 (-20.93%) and lowest in 2023 (-10,120.00%).
How does Orgenesis Inc.'s operating margin compare with similar companies?
Orgenesis Inc.'s operating margin (-10,120.00%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.